Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: Case report

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Masui, Toshihiko ^a   Kubota, Toyonari ^b   Aoki, Keiko ^b   Nakanishi, Yasutaka ^b   Miyamoto, Takumi ^b   Nagata, Junko ^b   Morino, Koshiro ^b   Fukugaki, Atsushi ^b   Takamura, Michio ^b   Sugimoto, Shinichi ^b   Onuma, Hideyuki ^b   Tokuka, Atsuo ^b  

^a KYOTO UNIVERSITY   (Japan)

^b SHIMANE PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Pancreatic cancer; Para aortic lymph node metastasis

Indexed keywords

AMYLASE; BILIRUBIN; GEMCITABINE;

ABDOMINAL TENDERNESS; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; DISEASE SEVERITY; END TO END ANASTOMOSIS; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PARA AORTIC LYMPH NODE METASTASIS; TUMOR VOLUME;

ADENOCARCINOMA; AORTA, ABDOMINAL; CARCINOMA, PANCREATIC DUCTAL; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84882676045     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-195     Document Type: Article

References (20)

1. Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control 2006, 17:403-409. 10.1007/s10552-005-0539-4, 16596292.
2. Egawa S, Sunamura M, Abe H, Motoi F, Fukuyama S, Matsuno S. Clinicopathological aspects of pancreatic cancer. Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 2005, 32:605-611. (in Japanese).
3. Livingston EH, Welton ML, Reber HA. Surgical treatment of pancreatic cancer. The United States experience. Int J Pancreatol 1991, 9:153-157.
4. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995, 76:1671-1677. 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R, 8635074.
5. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?. Ann Surg 1995, 221:59-66. 10.1097/00000658-199501000-00007, 1234495, 7826162.
6. Yamamoto M, Ohashi O, Saitoh Y. Japan Pancreatic Cancer Registry: current status. Pancreas 1998, 16:238-242. 10.1097/00006676-199804000-00006, 9548661.
7. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Yuasa Y, Sueda T. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma. World J Surg 2010, 34:1900-1907. 10.1007/s00268-010-0577-2, 20376442.
8. Doi R, Kami K, Ito D, Fujimoto K, Kawaguchi Y, Wada M, Kogire M, Hosotani R, Imamura M, Uemoto S. Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer. World J Surg 2007, 31:147-154. 10.1007/s00268-005-0730-5, 17171496.
9. Shimada K, Sakamoto Y, Sano T, Kosuge T. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. J Am Coll Surg 2006, 203:345-352. 10.1016/j.jamcollsurg.2006.05.289, 16931307.
10. Sakai M, Nakao A, Kaneko T, Takeda S, Inoue S, Kodera Y, Nomoto S, Kanazumi N, Sugimoto H. Para-aortic lymph node metastasis in carcinoma of the head of the pancreas. Surgery 2005, 137:606-611. 10.1016/j.surg.2005.02.009, 15933626.
11. Yoshida T, Matsumoto T, Sasaki A, Shibata K, Aramaki M, Kitano S. Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma. Am J Surg 2004, 187:736-740. 10.1016/j.amjsurg.2003.07.031, 15191867.
12. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Ueno K, Tajima H, Elnemr A, Miwa K. Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery?. Cancer 1999, 85:583-590. 10.1002/(SICI)1097-0142(19990201)85:3<583::AID-CNCR8>3.0.CO;2-J, 10091731.
13. House MG, Gonen M, Jarnagin WR, D'Angelica M, DeMatteo RP, Fong Y, Brennan MF, Allen PJ. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 2007, 11:1549-1555. 10.1007/s11605-007-0243-7, 17786531.
14. Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 2006, 13:1189-1200. 10.1245/s10434-006-9016-x, 16955385.
15. Michalski CW, Kleeff J, Wente MN, Diener MK, Buchler MW, Friess H. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 2007, 94:265-273. 10.1002/bjs.5716, 17318801.
16. Waraya M, Yamashita K, Katagiri H, Ishii K, Takahashi Y, Furuta K, Watanabe M. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer. Ann Surg Oncol 2009, 16:1231-1240. 10.1245/s10434-009-0415-7, 19263172.
17. Hatori T, Yoshikawa T, Nakasato T, Harada N, Takasaki K. Strategy of surgical management for invasive ductal adenocarcinoma of the pancreas by clinical analysis of the long-term survivors. Nihon Shokaki Gekagakkaishi (Jpn J Gastroenterology) 1999, 32:1089-1093.
18. Massucco P, Ribero D, Sgotto E, Mellano A, Muratore A, Capussotti L. Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers. Ann Surg Oncol 2009, 16:3323-3332. 10.1245/s10434-009-0672-5, 19777195.
19. Marechal R, Bachet JB, Mackey JR, Dalban C, Demetter P, Graham K, Couvelard A, Svrcek M, Bardier-Dupas A, Hammel P, Sauvanet A, Louvet C, Paye F, Rougier P, Penna C, Andre T, Dumontet C, Cass CE, Jordheim LP, Matera EL, Closset J, Salmon I, Deviere J, Emile JF, Van Laethem JL. Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Gastroenterology 2012, 143:e6-e674. 10.1053/j.gastro.2012.04.013, 23010298.
20. Kato K, Kondo S, Hirano S, Tanaka E, Shichinohe T, Tsuchikawa T, Matsumoto J. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy. J Hepatobiliary Pancreat Sci 2011, 18:712-716. 10.1007/s00534-011-0391-8, 21455748.